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Malignant lymphoma B-cell type is the most common canine haematopoietic malignancy.
Changes in intestinal microbiota have been implicated in few types of cancer in humans. The
aim of this prospective and case-control study was to determine differences in faecal micro-
biota between healthy control dogs and dogs with multicentric lymphoma. Twelve dogs
affected by multicentric, B-cell, stage III-IV lymphoma, and 21 healthy dogs were enrolled in
the study. For each dog, faecal samples were analysed by Illumina sequencing of 16S rRNA
genes and quantitative PCR (qPCR) for selected bacterial groups. Alpha diversity was significant
lower in lymphoma dogs. Principal coordinate analysis plots showed different microbial cluster-
ing (P = .001) and linear discriminant analysis effect size revealed 28 differentially abundant
bacterial groups in lymphoma and control dogs. The qPCR analysis showed significant lower
abundance of Faecalibacterium spp. (q < .001), Fusobacterium spp. (q = .032), and Turicibacter
spp. (q = .043) in dogs with lymphoma compared with control dogs. On the contrary, Strepto-
coccus spp. was significantly higher in dogs with lymphoma (q = .041). The dysbiosis index was
significantly higher (P < .0001) in dogs with lymphoma. In conclusion, both sequencing and
qPCR analyses provided a global overview of faecal microbial communities and showed signifi-
cant differences in the microbial communities of dogs presenting with multicentric lymphoma
compared with healthy control dogs.
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1 | INTRODUCTION
Malignant lymphoma is the most common haematopoietic malignancy
in dogs, caused by clonal proliferation of lymphocytes in solid tissue
with distinctive morphologic and immunophenotypic features. Canine
lymphoma is the most common canine malignancy, accounting for up
to 24% of all reported neoplasms. The annual incidence has been
estimated between 13 and 24 cases per 100 000 dogs. Similarly to
humans, the majority of canine lymphoma (60%-80%) arises from
malignant B cells.1,2
The intestinal microbiota of dogs consists of bacteria, fungi,
archaea, viruses, and protozoa. Animal models play a key role in
understanding the importance of gut microbiota composition in
immune system development, and its relation with health and
disease.3–5 Intestinal bacteria have been implicated in several types
of cancer. In animal models of colorectal cancer, lower incidences in
germ-free or antibiotic-treated animals point towards intestinal
microbes playing a causative role.5,6 Helicobacter spp. in mice have
been associated with enhanced carcinogenesis in some cancers,
including gastric cancer, liver cancer, colon cancer, and mammary
carcinoma.7 Similarly, dysbiosis of the colon is suspected as being
involved in colonic carcinogenesis.8 Microbes influence immune
cells, and increased lymphocyte proliferation can lead to a higher
chance of aberrant DNA replication. This particularly occurs with
some B lymphocytes which are innately vulnerable to genetic insta-
bility and activation, and this may lead to neoplasia.9 Molecular
methods, mostly targeting the 16S rRNA gene, are now the recog-
nized standard for identification of microbiota. Such approaches
have demonstrated that the canine and feline gastrointestinal (GI)
tracts harbour a highly complex microbial ecosystem.10,11 However,
little information is known about the microbiota composition in vari-
ous canine neoplasia types.
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Therefore, the aim of this prospective and case-control study was
to determine differences in faecal microbiota between healthy dogs
and dogs with multi-centric lymphoma using 16S rRNA gene analyses.
2 | MATERIALS AND METHODS
2.1 | Animals and samplings
Fresh naturally voided faecal samples were collected from 12 dogs
with lymphoma and 21 healthy dogs (Table 1) and were immediately
stored at −80C until analysis. This study was approved by the Uni-
versity of Pisa Institutional Animal Experimental Use Committee
(0009069/2014). Written informed consent was obtained from all
owners of enrolled dogs.
Dogs with lymphoma: All dogs were affected by malignant lym-
phoma (diffuse large B-cell lymphoma), generalized lymphadenopathy
anatomic form (multicentric), stage III or IV (WHO clinical staging for
lymphoma) without systemic signs. Animals selected were not show-
ing any additional clinical signs of significant disease, and they were
in good general condition. None of the dogs showed any gastrointes-
tinal signs in the past 2 months, and none received antibiotics within
at least the previous 2 months before faecal sample collection. One
dog received prednisone 1 week before sample collection.
Healthy control dogs: All control dogs were apparently healthy at
the time of sample collection. None of the dogs showed any GI signs
in the past 2 months, and none received antibiotics within at least
the previous 2 months before faecal sample collection. A complete
blood count and serum biochemistry profiles were conducted both
for dogs with lymphoma and for healthy control dogs.
2.2 | Evaluation of faecal microbiota
2.2.1 | DNA extraction
An aliquot of 100 mg (wet weight) of each faecal sample was
extracted by a bead-beating method using a MoBio Power soil DNA
isolation kit (MoBio Laboratories, Carlsbad, CA, USA) following the
manufacturer’s instructions. The bead-beating step was performed on
a homogenizer (FastPrep-24, MP Biomedicals LLC, Santa Ana, CA,
USA) for 60 seconds at a speed of 4 m/s.
2.2.2 | Illumina sequencing of 16S rRNA genes
Sequencing data were utilized to evaluate bacterial communities in
faecal samples from enrolled dogs. The V4 region of the 16S rRNA
gene was amplified with primers 515F (50-GTGCCAGCMGCCGCGG-
TAA-30) and 806R (50-GGACTACVSGGGTATC TAAT-30) at the MR
DNA Laboratory (Shallowater, Texas) as previously described.12 The
raw sequence data were screened, trimmed, filtered, denoised, and
barcodes and chimera sequences were depleted from the dataset
using QIIME v1.8 pipeline and USEARCH. Operational Taxonomic
Units (OTUs) were assigned based on at least 97% sequence similar-
ity against the Greengenes reference database. Sequences were rare-
fied to an even depth of 16 630 sequences per sample to account for
unequal sequencing depth across samples. Observed species richness,
Chao 1, and Shannon indexes were determined using QIIME. The
sequences were deposited in sequence read archive (SRA) under
accession number SRP102663.
2.2.3 | Quantitative PCR (qPCR)
The qPCR assays for selected bacterial groups (total bacteria, Faecali-
bacterium spp., Turicibacter spp., Streptococcus spp., Escherichia coli,
Blautia spp., Fusobacterium spp., and Clostridium hiranonis) were per-
formed to validate in part the sequencing results. The results were
also combined and reported as a recently reported qPCR dysbiosis
index.13 The qPCR cycling, the oligonucleotide sequences of primers,
and respective annealing temperatures for selected bacterial groups
were described previously.14,15 A commercial real-time PCR thermal
cycler (CFX 96 Touch Real-Time PCR Detection System; Biorad Labo-
ratories, Hercules, California) was used for all qPCR assays and all
samples were run in duplicate fashion.
2.3 | Statistical analysis
2.3.1 | Sequencing data
Differences in microbial communities between animal groups were
determined using the phylogeny based on the weighted and
unweighted UniFrac distance metrixies, and Principal Coordinate
Analysis (PCoA) plots and rarefaction curves were plotted using
QIIME. The analysis of similarities (ANOSIM) was performed on the
UniFrac distance matrixes for statistical analysis. Linear discriminant
analysis (LDA) effect size (LEfSe: http://huttenhower.sph.harvard.
edu/galaxy/) was utilized to evaluate differentially abundant bacterial
taxa between the animal groups. A Mann-Whitney test was utilized to
evaluate differences in relative abundances of bacterial taxa between
healthy control dogs and dogs with lymphoma. The Benjamini &
Hochberg’s false discovery rate was utilized to report a q value. 16
2.3.2 | qPCR data
For all qPCR datasets, statistical analysis was performed using com-
mercial available software (Prism version 6.0, Graph Pad Software
Inc). Data normality was tested using the D’Agostino and Pearson
normality test. The differences in the abundance of bacterial group
and the dysbiosis index between animal groups were determined
using a Student’s t-test. The Benjamini & Hochberg’s false discovery
rate was used to correct for multiple comparisons and adjusted at
P < .05 (ie, q < .05) was considered to be statistically significant.16
3 | RESULTS
3.1 | Study population
The characteristics of the enrolled dogs and the clinical/clinico-
pathological findings of dogs with lymphoma are summarized in
Table 1. All dogs were negative for faecal parasites. All dogs with
lymphoma showed only generalized lymphoadenopathy and their
general conditions were satisfying. These dogs showed mild alter-
ations in hematobiochemical profiles and in some cases presented
with hepato-splenomegaly documented clinically and by ultrasound
procedure, as a typical component of this type of disease. The most
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frequent alteration was an increase in LDH levels that is common in
canine lymphoma and in cancer.17 Dogs with lymphoma and control
cases were fed with a variety of commercial diets. The mean ( stan-
dard deviation) age of dogs with lymphoma and control dogs was
8.1 years 1.4 and 6.5 years 3.0, respectively (P = .085). Of the
dogs with lymphoma, 7 were males and 5 were females. Of the con-
trol dogs, 10 were males and 11 were females. There was no signifi-
cant difference between the genders between the 2 groups (Fisher’s
exact test; P = .720). The mean ( standard deviation) body weight
of dogs with lymphoma and control dogs were 24.5 kg  13.4 and
24.2 kg  8.9, respectively (P = 0.955).
3.2 | Sequencing analysis
A total of 24 DNA samples from dogs with lymphoma (n = 12) and
healthy control dogs (n = 12) were available for the sequencing analy-
sis. The Illumina sequencing pipeline yielded a total of 1 032 003
quality sequences with an average of 28 666 sequences per sample
TABLE 1 Signalment of the enrolled dogs
Breed Sex Age (years) Body weight (kg) Clinical/clinico pathological signs
Lymphoma dogs
1 Jack Russell Terrier m 7 10 Splenomegaly;
Increased CRP, LDH
2 Labrador Retriever m 9 43 Splenomegaly; hepatomegaly;
Increased LDH
3 Dachshund m 10 8 Increased LDH
4 Jack Russell Terrier m 6 8 Mild thrombocytopenia;
Spleno-hepatomegaly
Increased ALP, GGT, ALT, AST, LDH
5 Beagle f 8 16 Increased LDH
6 Labrador Retriever f 9 36 Increased ALP
7 Belgian Shepherd m 7 34 –
8 Hound f 6 23 Splenomegaly
9 Beagle m 9 17 –
10 Mixed f 9 20 Increased ALP, ALT, AST, LDH
11 Doberman f 10 34 Increased CRP, LDH
12 Mixed m 8 45 Mild anaemia;
Increased ALP, CRP
Healthy dogs
13 Boxer m 5 31
22 Pit Bull Terrier mc 4 30
23 Boston Terrier fs 3 12
24 Labrador Retriever mc 2 36
14 Boxer f 7 24
32 Mixed fs 11 40
25 Dachshund mc 6 5
15 Boxer f 4 22
16 Boxer f 9 31
28 Mixed mc 7 26
29 Labrador Retriever mc 10 29
30 Beagle mc 5 9
17 Boxer f 3 24
20 Mixed f 4 26
21 Mixed f 4 22
18 Boxer f 4 25
19 Boxer f 8 29
26 Brittany Spaniel mc 11 21
27 Jack Russel terrier mc 9 10
31 Weimaraner mc 11 27
33 Mixed fs 10 30
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPR: C-reactive protein; f, female; fs, spayed
female; LDH, lactate dehydrogenase; m, male; mc, castrated male.
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(range: 16 638-35 270). To account for unequal sequencing depth
across samples, the subsequent analysis was performed on a ran-
domly selected subset of 16 630 sequences per sample. A total of
6 phyla and 61 genera were identified.
Alpha diversity measures revealed a significantly lower diversity
in dogs with lymphoma (Figure 1 and Table 2). PCoA plots of
unweighted UniFrac distances showed different microbial clustering
in the 2 groups of dogs (ANOSIM R = .33, P = .001; Figure 2). LefSe
detected a total of 28 differentially abundant bacterial taxa (α = .05,
LDA score > 2.0, Figure 3). Univariate analysis of relative abundance
of predominant bacterial taxa at phylum, class, order, family, and
genus level is summarized in Table S1 (Supporting Information).
3.3 | qPCR analysis of selected bacterial groups and
dysbiosis index
A total of 33 DNA samples from dogs with lymphoma (n = 12) and
healthy control dogs (n = 21) were available for qPCR analysis. Signif-
icantly lower abundance of Faecalibacterium spp. (q < .001), Fusobac-
terium spp. (q = .032), and Turicibacter spp. (q = .043) was observed
in dogs with lymphoma compared with healthy control dogs. The
abundance of Streptococcus spp. was significantly higher in dogs with
lymphoma compared with healthy control dogs (q = .041;Table 3). Of
those 3 above bacterial taxa, Faecalibacterium spp. was also signifi-
cantly lower in dogs with lymphoma in the sequencing analysis
(Figure 4). The dysbiosis index was significantly higher (P < .0001) in
dogs with lymphoma (Table 3 and Figure 5).
4 | DISCUSSION
The multivariate analysis based on 16S rRNA gene sequencing and
the multivariate analysis of qPCR data (dysbiosis index) provided a
global overview of faecal microbial communities and both analysis
showed that the microbiota differ between healthy control dogs and
dogs with lymphoma. In the sequencing data, several differentially
abundant bacterial groups between dogs with lymphoma and healthy
control dogs were identified. Of interest is that bacterial families that
are generally believed to be associated with gut health like Rumino-
coccaceae, Prevotellaceae, and Erysipelotrichaceae were decreased in
dogs with lymphoma. This was also manifested on the genus level
with decreases in genus Ruminococcus and Prevotella in lymphoma
dogs, although interestingly one unclassified Ruminococcus was signif-
icantly increased in dogs with lymphoma based on LefSe. In the
sequencing data Turicibacter and Fusobacterium showed trends
towards a decreased abundance in dogs with lymphoma, and these
2 bacterial taxa were confirmed to be significantly decreased on
qPCR. Faecalibacterium spp. appeared to be one of the strongest
drivers of the microbiota differences between both groups. Studies
have shown a lower abundance of Faecalibacterium spp. in dogs with
inflammatory bowel disease (IBD) compared with healthy control
dogs.18,19 This result is important because this genus is considered an
important immune-modulatory bacterial group and one of their bac-
terial species, Faecalibacterium prausnitzii has also been found to be
consistently decreased in human inflammatory bowel disease (IBD)
patients and it is considered an important bacterial taxa for maintain-
ing microbial homeostasis. Interestingly, lower levels of F. prausnitzii
were recently found in humans with some chronic colonic conditions
as well as colorectal cancer compared with healthy subjects.20 Pres-
ence of high faecal dysbiosis index in dogs with multicentric lym-
phoma was of interest because none of the lymphoma dogs showed
any clinical signs of GI disease. This may suggest an association
between the GI microbiota and systemic neoplastic disorder, which
was subclinical at the time of sample collection. The microbiota
results resembled those as previously reported in intestinal conditions
with mucosal infiltration and changes in villous architecture. It would
FIGURE 1 Rarefaction analysis of 16S rRNA gene for healthy and
lymphoma affected dogs. Lines represent the mean and error bars
represent standard deviations
TABLE 2 Alpha diversity measures
Measures
Healthy Lymphoma
Mean  SD Mean  SD P value
Chao1 2084.67 390.86 1661.67 326.80 0.003
Observed_species 792.08 71.88 700.58 81.59 0.004
Shannon index 5.31 0.69 4.60 0.63 0.003
SD, standard deviation.
FIGURE 2 Principal coordinates analysis of unweighted UniFrac
distances of 16S rRNA gene. Analysis of similarity revealed clustering
between dogs with lymphoma and healthy control dogs
(R = .33, P = .001)
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be interesting to know the extent of intestinal abnormality and the
identity of the mucosa adherent bacterial species, as faecal micro-
biota may not reveal the mucosal colonization.21 Unfortunately,
owing to the absence of GI clinical signs, histological evaluation of a
GI tissue sample from the enrolled dogs was not conducted in this
study. Further studies evaluating faecal microbiota and complete
staging including histological evaluation of the GI tract in dogs with
multicentric lymphoma are warranted. Faecal dysbiosis has been
shown to be associated with significant changes in bacterial and/or
host metabolism such as faecal short chain fatty acids (SCFAs) (eg,
propionate, acetate, and butyrate), and the serum and urine metabo-
lite profiles.22 Furthermore, propionic acid was significantly correlated
with a loss in SCFAs producing bacteria (ie, Faecalibacterium spp.),
similarly to what happened in our patients. SCFAs have anti-
inflammatory properties, since they induce immune-regulatory T cells
(Treg).22 A recent study showed that butyrate production from high-
fibre diet inhibited the growth of lymphoma tumours and induced
apoptosis of lymphoma tumour cells and significantly up-regulated
histone 3 acetylation (H3ac) level and target genes, such as Fas, P21,
P27.23
While we observed an association between faecal microbiota
and multicentric lymphoma, future studies are needed to evaluate
whether these microbiota changes persist or improve with therapy,
or even whether the microbiota may have an effect on chemotherapy
itself.24 Furthermore, even if microbiota changes may be a conse-
quence of lymphoma, it may seem prudent in the future to develop
additional treatment strategies that would help in restoration of gut
microbiota, given our evolving understanding of the importance of
normal microbiota composition on immune homeostasis.25,26 For
example, probiotic formulations containing lactic acid bacteria have
been shown to reduce the incidence of chemically mediated hepato-
cellular carcinoma and colon cancer in rats.25 Some studies report
that administration of probiotics and prebiotics could be an important
preventive factor for chemoprevention strategies.27
There are limitations that need to be addressed. First, our cohort
of dogs was living in different environments and was fed a variety of
diets, and these can be confounding factors of microbial analysis.
However, previous studies showed that disease is a larger driver of
microbiota differences than potential confounding factors, such as
FIGURE 3 Linear discriminant analysis (LDA) effect size of Illumina
pyrosequencing datasets based on 16S rRNA gene sequences.
Histogram of the LDA scores computed for differentially abundant
bacterial taxa between dogs with multicentric lymphoma and control
TABLE 3 Abundances of selected bacterial groups (qPCR)
Healthy Lymphoma
Bacterial group Mean (log DNA)  SD Mean (log DNA)  SD P value q value
Total bacteria 11.67 0.67 11.46 0.34 0.386 0.459
Faecalibacterium spp. 6.42 0.88 3.89 1.26 <0.0001 <0.001
Turicibacter spp. 6.55 1.24 5.33 1.32 0.022 0.043
Streptococcus spp. 5.03 1.33 6.40 1.34 0.016 0.041
Escherichia coli 6.57 1.37 7.22 1.65 0.277 0.443
Blautia spp. 9.55 1.16 9.18 0.97 0.402 0.459
Fusobacterium spp. 9.10 0.75 8.17 0.98 0.008 0.032
Clostridium hiranonis 5.83 1.88 5.67 1.89 0.837 0.837
Dysbiosis index −3.80 2.3 1.2 3.6 <0.0001 na
Abbreviations: na, not applicable; SD, standard deviation.
FIGURE 4 Comparison of the abundance of Faecalibacterium spp.
based on qPCR analysis and Illumina sequencing analysis. Bars
represent the mean log DNA (qPCR data) or mean relative abundance
(sequencing data)
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diet, age, and body weight.19,21 Second, one-third of enrolled dogs in
the healthy control group were Boxer dogs. Only limited information
is available regarding the influence of dog breed on faecal microbiota.
However, recent studies utilizing Illumina sequencing showed no dif-
ferences in microbial communities (diversity and richness) based on
the breed of dogs, especially when compared with the disease pheno-
type.21,28,29 Finally, the small sample size in this study may limit the
statistical power. Further studies with large sample size are warranted
to confirm out findings in this current study. In conclusion, we
showed significant differences in the faecal microbial communities of
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